A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.

Abstract

Tenoxicam (TILCOTIL, MOBIFLEX) 40 mg/day has been compared to piroxicam 40 mg/day in a double-blind, parallel group study of 4 weeks duration in 30 patients with osteoarthrosis. Both drugs were well tolerated, tenoxicam slightly better than piroxicam. Both drugs improved general pain, improvement being greater with tenoxicam. Little improvement of other symptoms was seen with either treatment. At the end of the study, 12 tenoxicam-treated patients and seven piroxicam-treated patients elected to remain on their respective treatment.

• Authors: H A Bird, J Hill, J S Dixon, D Looi, V Wright
• Journal: European journal of rheumatology and inflammation (Eur J Rheumatol Inflamm) Vol. 8 Issue 1 Pg. 53-9 ( 1985) ISSN: 0140-1610 [Print] England
• PMID: 3915888 (Publication Type: Clinical Trial, Comparative Study, Journal Article)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Piroxicam
• tenoxicam

Topics

• Adult
• Aged
• Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
• Clinical Trials as Topic
• Double-Blind Method
• Female
• Humans
• Male
• Middle Aged
• Osteoarthritis (drug therapy)
• Piroxicam (analogs & derivatives, therapeutic use)